Search Results - "Remenar, E." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study

by Psyrri, A., Fortpied, C., Koutsodontis, G., Avgeris, M., Kroupis, C., Goutas, N., Menis, J., Herman, L., Giurgea, L., Remenár, É., Degardin, M., Pateras, I.S., Langendijk, J.A., van Herpen, C.M.L., Awada, A., Germà-Lluch, J.R., Kienzer, H.R., Licitra, L., Vermorken, J.B.
Published in Annals of oncology (01.09.2017)

Get full text

Journal Article

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

by Vermorken, J.B., Peyrade, F., Krauss, J., Mesía, R., Remenar, E., Gauler, T.C., Keilholz, U., Delord, J.P., Schafhausen, P., Erfán, J., Brümmendorf, T.H., Iglesias, L., Bethe, U., Hicking, C., Clement, P.M.
Published in Annals of oncology (01.03.2014)

Get full text

Journal Article

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial

by Specenier, P.M., Remenar, E., Buter, J., Schrijvers, D.L., Bergamini, C., Licitra, L.F., Awada, A., Clement, P.M., Fortpied, C., Menis, J., Vermorken, J.B.
Published in Annals of oncology (01.09.2017)

Get full text

Journal Article

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)

Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971 TAX 323)

by VAN HERPES, Cml, MAUER, M. E, PREISS, J. H, VAN DEN WEYNGAERT, D, BOTTOMLEY, A, VERMORKEN, J. B, MESIA, R, DEGARDIN, M, JELIC, S, COENS, C, BETKA, J, BERNIER, J, REMENAR, E, STEWART, J. S
Published in British journal of cancer (12.10.2010)

Get full text

Journal Article

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

by Remenar, E, Lövey, J, Koltai, P, Horvath, K, Gödeny, M, Kasler, M
Published in European journal of cancer (1990) (2011)

Get full text

Journal Article

The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial

The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial

by Tímár, József, Forster-Horváth, C, Lukits, J, Döme, B, Ladányi, A, Remenár, E, Kásler, M, Bencsik, M, Répássy, G, Szabó, G, Velich, N, Suba, Z, Elõ, J, Balatoni, Z, Bajtai, A, Chretien, P, Talor, Eyal
Published in The Laryngoscope (01.12.2003)

Get more information

Journal Article

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

by Vermorken, J. B., Remenar, E., van Herpen, C., Germa Lluch, J., Stewart, S., Gorlia, T., Degardin, M., Schollen, K., Bernier, J.
Published in Journal of clinical oncology (15.07.2004)

Get full text

Journal Article

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971)

by Vermorken, J. B., Remenar, E., van Herpen, C., Germa Lluch, J., Stewart, S., Gorlia, T., Degardin, M., Schollen, K., Bernier, J.
Published in Journal of clinical oncology (15.07.2004)

Get full text

Journal Article

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

by Soulières, D, Faivre, S, Mesía, R, Remenár, E, Li, S.H, Karpenko, A, Dechaphunkul, A, Keilholz, U, Kiss, L, Lin, J.C, Nagarkar, R, Tamás, L, Kim, S.B, Erfán, J, Alyasova, A, Yovine, A, Le Mouhaër, S, Solovieff, N, Turri, S, Licitra, L
Published in Radiotherapy and oncology (01.03.2017)

Get full text

Journal Article

5548 POSTER Circulating hormone levels and prognosis in head and neck cancer

5548 POSTER Circulating hormone levels and prognosis in head and neck cancer

by Remenar, E, Vincze, B, Szamel, I, Ladanyi, A, Timar, J, Kasler, M
Published in European journal of cancer supplements (2007)

Get full text

Journal Article

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

by Licitra, L., Mesia, R., Rivera, F., Remenár, É., Hitt, R., Erfán, J., Rottey, S., Kawecki, A., Zabolotnyy, D., Benasso, M., Störkel, S., Senger, S., Stroh, C., Vermorken, J.B.
Published in Annals of oncology (01.05.2011)

Get full text

Journal Article

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease

by Harrington, Kevin, Berrier, Alain, Robinson, Martin, Remenar, Eva, Housset, Martin, de Mendoza, Fernando Hurtado, Fayette, Jérôme, Mehanna, Hisham, El-Hariry, Iman, Compton, Natalie, Franklin, Natalie, Biswas-Baldwin, Nigel, Lau, Mike, Legenne, Philippe, Kumar, Rejnish
Published in European journal of cancer (1990) (01.05.2013)

Get full text

Journal Article

Cetuximab and platinum-based chemoradio-or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial

Cetuximab and platinum-based chemoradio-or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial

by HITRE, E, BUDAI, B, TAKACSI-NAGY, Z, RUBOVSZKY, G, TOTH, E, REMENAR, É, POLGAR, C, LANG, I
Published in British journal of cancer (03.09.2013)

Get full text

Journal Article

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase 1/11 ADVANTAGE trial (phase II part)

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase 1/11 ADVANTAGE trial (phase II part)

by VERMORKEN, J. B, PEYRADE, F, BRÜMMENDORF, T. H, IGLESIAS, L, BETHE, U, HICKING, C, CLEMENT, P. M, KRAUSS, J, MESIA, R, REMENAR, E, GAULER, T. C, KEILHOLZ, U, DELORD, J. P, SCHAFHAUSEN, P, ERFAN, J
Published in Annals of oncology (2014)

Get full text

Journal Article

Long-term results from EORTC24971/TAX323: Comparing TPF to PF in patients with unresectable squamous cell carcinoma of the head and neck (SCCHN)

Long-term results from EORTC24971/TAX323: Comparing TPF to PF in patients with unresectable squamous cell carcinoma of the head and neck (SCCHN)

by Vermorken, J. B., Remenar, E., Van Herpen, C., Degardin, M., Stewart, J. S., Karra Gurunath, R., Fortpied, C.
Published in Journal of clinical oncology (20.05.2011)

Get full text

Journal Article

Biomarker potential of EGFR gene copy number by FISH in the phase III EXTREME study: Platinum-based CT plus cetuximab in first-line R/M SCCHN

Biomarker potential of EGFR gene copy number by FISH in the phase III EXTREME study: Platinum-based CT plus cetuximab in first-line R/M SCCHN

by Licitra, L., Rolland, F., Bokemeyer, C., Remenar, E., Kienzer, H., Stoerkel, S., Scheid, S., Stroh, C., Mesia, R.
Published in Journal of clinical oncology (20.05.2009)

Get full text

Journal Article

Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer

Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer

by Lukits, J, Remenár, E, Rásó, E, Ladányi, A, Kásler, M, Tímár, J
Published in International journal of oncology (01.01.2007)

Get full text

Journal Article

Progression of head and neck squamous cell cancer

Progression of head and neck squamous cell cancer

by Tímár, József, Csuka, Orsolya, Remenár, Eva, Répássy, Gábor, Kásler, Miklós
Published in Cancer and metastasis reviews (01.01.2005)

Get full text

Journal Article

The morphological basis for development of Reinke's oedema

The morphological basis for development of Reinke's oedema

by Remenár, E, Elö, J, Frint, T
Published in Acta oto-laryngologica (01.01.1984)

Get more information

Journal Article

Malignant mucosal melanoma of the head and neck

Malignant mucosal melanoma of the head and neck

by Lengyel, Erzsébet, Gilde, Katalin, Remenár, Eva, Esik, Olga
Published in Pathology oncology research (2003)

Get full text

Journal Article